Aslani, Nikka M.
HRN: 21-81-63 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2025
MUPIROCIN 2%, 15G (TUBE)
08/31/2025
09/06/2025
TOPICAL
Squirt
BID
7days
Checking Initial Appropriateness
08/31/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/31/2025
09/06/2025
IVT
120mg
Q6
Skin Infection
Checking Initial Appropriateness
09/01/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/01/2025
09/08/2025
PO
5ml
TID
Amoebiasis
Checking Initial Appropriateness